Dr Donald D Accetta, MD, MPH - Medicare Allergy/immunology in Taunton, MA

Dr Donald D Accetta, MD, MPH is a medicare enrolled "Allergy & Immunology - Allergy" physician in Taunton, Massachusetts. He graduated from medical school in 1976 and has 48 years of diverse experience with area of expertise as Allergy/immunology. He is a member of the group practice Allergy And Asthma Care Pc and his current practice location is 101 Industrial Park Road, Suite 307, Taunton, Massachusetts. You can reach out to his office (for appointments etc.) via phone at (508) 880-3121.

Dr Donald D Accetta is licensed to practice in Massachusetts (license number 44394) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1891798138.

Contact Information

Dr Donald D Accetta, MD, MPH
101 Industrial Park Road, Suite 307,
Taunton, MA 02780
(508) 880-3121
(808) 880-0926



Physician's Profile

Full NameDr Donald D Accetta
GenderMale
SpecialityAllergy/immunology
Experience48 Years
Location101 Industrial Park Road, Taunton, Massachusetts
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Donald D Accetta graduated from medical school in 1976
  NPI Data:
  • NPI Number: 1891798138
  • Provider Enumeration Date: 05/31/2005
  • Last Update Date: 10/14/2013
  Medicare PECOS Information:
  • PECOS PAC ID: 9335184407
  • Enrollment ID: I20050621000172

Medical Identifiers

Medical identifiers for Dr Donald D Accetta such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1891798138NPI-NPPES
2070103MedicaidMA

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207KA0200XAllergy & Immunology - Allergy 44394 (Massachusetts)Primary

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Allergy And Asthma Care Pc95372338383

News Archive

Optimer Pharmaceuticals announces results from second Phase 3 clinical study of fidaxomicin

Optimer Pharmaceuticals, Inc. announced that the top-line results from its second fidaxomicin Phase 3 clinical study in patients with Clostridium difficile infection were presented today at the 20th Annual European Congress of Clinical Microbiology and Infectious Diseases in Vienna, Austria.

Rationality of infants has been overstated, finds study

In a widely noticed study, developmental psychologists reported that 14-month-old infants imitate an unusual action if it was chosen deliberately by the person they observed, but not if it could be attributed to external constraints. This selective imitation was put forth as evidence for an early understanding of rational action and action goals.

HHS global health official discusses tobacco-, drug patent-related trade negotiations

Inside U.S. Trade features an interview with HHS Assistant Secretary forAffairs Nils Daulaire, who discusses how "the department is playing a larger role than ever before in the development of U.S. trade policy, including on sensitive issues in the Trans-Pacific Partnership (TPP) negotiations like a draft proposal for a tobacco-specific 'safe harbor' and the U.S. stance on issues related to intellectual property protections for pharmaceuticals," according to the publication.

UA researchers one step closer to preventing asthma in children

Efforts to improve the health of children at increased risk for asthma will receive a major boost with the launch of a new University of Arizona Health Sciences-led, federally funded national clinical study. For Fernando D. Martinez, MD, and his colleagues at the UA Asthma and Airway Disease Research Center, this study follows 30 years of research to prevent and cure this chronic disease.

Anxiety, depression associated with increased opioid use following surgery

Surgeons wielding their life-saving scalpels, laparoscopic tools, or other implements to repair or remove what ails their patients understand all too well that pain is an unavoidable part of the healing process. Yet the current opioid crisis has made the standard prescribing practices for these highly effective analgesics fraught with risk.

Read more Medical News

› Verified 8 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Donald D Accetta allows following entities to bill medicare on his behalf.
Entity NameAllergy & Asthma Care Pc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1942370010
PECOS PAC ID: 9537233838
Enrollment ID: O20080805000411

News Archive

Optimer Pharmaceuticals announces results from second Phase 3 clinical study of fidaxomicin

Optimer Pharmaceuticals, Inc. announced that the top-line results from its second fidaxomicin Phase 3 clinical study in patients with Clostridium difficile infection were presented today at the 20th Annual European Congress of Clinical Microbiology and Infectious Diseases in Vienna, Austria.

Rationality of infants has been overstated, finds study

In a widely noticed study, developmental psychologists reported that 14-month-old infants imitate an unusual action if it was chosen deliberately by the person they observed, but not if it could be attributed to external constraints. This selective imitation was put forth as evidence for an early understanding of rational action and action goals.

HHS global health official discusses tobacco-, drug patent-related trade negotiations

Inside U.S. Trade features an interview with HHS Assistant Secretary forAffairs Nils Daulaire, who discusses how "the department is playing a larger role than ever before in the development of U.S. trade policy, including on sensitive issues in the Trans-Pacific Partnership (TPP) negotiations like a draft proposal for a tobacco-specific 'safe harbor' and the U.S. stance on issues related to intellectual property protections for pharmaceuticals," according to the publication.

UA researchers one step closer to preventing asthma in children

Efforts to improve the health of children at increased risk for asthma will receive a major boost with the launch of a new University of Arizona Health Sciences-led, federally funded national clinical study. For Fernando D. Martinez, MD, and his colleagues at the UA Asthma and Airway Disease Research Center, this study follows 30 years of research to prevent and cure this chronic disease.

Anxiety, depression associated with increased opioid use following surgery

Surgeons wielding their life-saving scalpels, laparoscopic tools, or other implements to repair or remove what ails their patients understand all too well that pain is an unavoidable part of the healing process. Yet the current opioid crisis has made the standard prescribing practices for these highly effective analgesics fraught with risk.

Read more Medical News

› Verified 8 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Donald D Accetta is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Donald D Accetta, MD, MPH
101 Industrial Park Road, Suite 307,
Taunton, MA 02780

Ph: (508) 880-3121
Dr Donald D Accetta, MD, MPH
101 Industrial Park Road, Suite 307,
Taunton, MA 02780

Ph: (508) 880-3121

News Archive

Optimer Pharmaceuticals announces results from second Phase 3 clinical study of fidaxomicin

Optimer Pharmaceuticals, Inc. announced that the top-line results from its second fidaxomicin Phase 3 clinical study in patients with Clostridium difficile infection were presented today at the 20th Annual European Congress of Clinical Microbiology and Infectious Diseases in Vienna, Austria.

Rationality of infants has been overstated, finds study

In a widely noticed study, developmental psychologists reported that 14-month-old infants imitate an unusual action if it was chosen deliberately by the person they observed, but not if it could be attributed to external constraints. This selective imitation was put forth as evidence for an early understanding of rational action and action goals.

HHS global health official discusses tobacco-, drug patent-related trade negotiations

Inside U.S. Trade features an interview with HHS Assistant Secretary forAffairs Nils Daulaire, who discusses how "the department is playing a larger role than ever before in the development of U.S. trade policy, including on sensitive issues in the Trans-Pacific Partnership (TPP) negotiations like a draft proposal for a tobacco-specific 'safe harbor' and the U.S. stance on issues related to intellectual property protections for pharmaceuticals," according to the publication.

UA researchers one step closer to preventing asthma in children

Efforts to improve the health of children at increased risk for asthma will receive a major boost with the launch of a new University of Arizona Health Sciences-led, federally funded national clinical study. For Fernando D. Martinez, MD, and his colleagues at the UA Asthma and Airway Disease Research Center, this study follows 30 years of research to prevent and cure this chronic disease.

Anxiety, depression associated with increased opioid use following surgery

Surgeons wielding their life-saving scalpels, laparoscopic tools, or other implements to repair or remove what ails their patients understand all too well that pain is an unavoidable part of the healing process. Yet the current opioid crisis has made the standard prescribing practices for these highly effective analgesics fraught with risk.

Read more News

› Verified 8 days ago


Allergy & Immunology Doctors in Taunton, MA

Dr. Deborah Jean Accetta Pedersen, M.D.
Allergy & Immunology
Medicare: Accepting Medicare Assignments
Practice Location: 101 Industrial Park Rd, Suite 307, Taunton, MA 02780
Phone: 508-880-3121    Fax: 508-880-0926
Hormoz Solomon, MD
Allergy & Immunology
Medicare: Accepting Medicare Assignments
Practice Location: 101 Industrial Park Rd Ste 700, Taunton, MA 02780
Phone: 508-880-3121    Fax: 088-800-9265

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.